ReviewFrontiers in immunology2022

Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147/EMMPRIN to Prevent Tumor Recurrence?

Michal A RahatPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.